Clinical trial
Cytoprotective Agent for Peptic Ulcer Prevention in Patients Taking Dual Antiplatelet Agents: A Randomized Double-blind Placebo Control Trial Study
NCT02166008 is registered in ClinicalTrials.gov with King Chulalongkorn Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cytoprotective Agent for Peptic Ulcer Prevention in Patients Taking Dual Antiplatelet Agents: A Randomized Double-blind Placebo Control Trial Study
- Lead sponsor
- King Chulalongkorn Memorial Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- June 30, 2018
- Enrollment
- 142 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
duodenal ulcer induced by anti-platelet agent, gastric ulcer induced by anti-platelet agent